RBX1 and urinary bladder carcinoma: demonstrated that RBX1 can activate the hedgehog pathway through the ubiquitinate suppressor of fused homolog (SUFU) for degradation, and dysregulation of the RBX1–SUFU–GLI2 axis play a pivotal role in bladder cancer progression (47).